Back to mobile site

Wolfe Research Starts Axsome Therapeutics (AXSM) at Outperform

February 23, 2026 4:05 PM EST Send to a Friend
(Updated - February 24, 2026 9:04 AM EST)

Wolfe Research analyst Rudy Li initiates coverage on Axsome Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login